How Much Do Patients Need to Know About a Potentially Risky Treatment?

An unapproved product made from umbilical cord blood was used at a prominent New York hospital. After an F.D.A. warning came an internal complaint: Patients should have been told.

View original article
Contributor: Ellen Gabler, Steve Eder and Allie Pitchon